Jpmorgan Chase & CO Baxter International Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Baxter International Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,414,312 shares of BAX stock, worth $98.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,414,312

Previous 3,298,679 3.51%

Holding current value

$98.5 Million

Previous $96.2 Million 21.5%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$29.26 - $36.57 $3.38 Million - $4.23 Million	115,633 Added 3.51%	3,414,312 $117 Million
Q4 2024 Feb 12, 2025	SELL	$28.63 - $37.84 $40.5 Million - $53.5 Million	-1,413,422 Reduced 30.0%	3,298,679 $96.2 Million
Q3 2024 Dec 26, 2024	SELL	$32.85 - $40.26 $23.1 Million - $28.3 Million	-702,263 Reduced 12.97%	4,712,101 $179 Million
Q3 2024 Nov 08, 2024	SELL	$32.85 - $40.26 $23.1 Million - $28.3 Million	-702,263 Reduced 12.97%	4,712,101 $179 Million
Q2 2024 Dec 26, 2024	BUY	$32.87 - $43.55 $23.1 Million - $30.6 Million	702,263 Added 14.9%	5,414,364 $181 Million
Q2 2024 Aug 12, 2024	SELL	$32.87 - $43.55 $204 Million - $270 Million	-6,192,770 Reduced 53.35%	5,414,364 $181 Million
Q1 2024 Dec 26, 2024	BUY	$37.88 - $43.77 $261 Million - $302 Million	6,895,033 Added 146.33%	11,607,134 $496 Million
Q1 2024 May 10, 2024	SELL	$37.88 - $43.77 $26.4 Million - $30.5 Million	-696,895 Reduced 5.66%	11,607,134 $496 Million
Q4 2023 Dec 26, 2024	BUY	$31.71 - $38.95 $241 Million - $296 Million	7,591,928 Added 161.12%	12,304,029 $476 Million
Q4 2023 Feb 12, 2024	SELL	$31.71 - $38.95 $116 Million - $143 Million	-3,665,867 Reduced 22.95%	12,304,029 $476 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $239 Million - $315 Million	6,393,815 Added 66.77%	15,969,896 $603 Million
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $139 Million - $165 Million	3,470,681 Added 56.85%	9,576,081 $436 Million
Q1 2023 May 18, 2023	BUY	$37.58 - $52.57 $8.93 Million - $12.5 Million	237,504 Added 4.05%	6,105,400 $248 Million
Q1 2023 May 11, 2023	SELL	$37.58 - $52.57 $28.7 Million - $40.1 Million	-763,188 Reduced 11.51%	5,867,896 $238 Million
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $85.6 Million - $99.4 Million	1,723,025 Added 35.11%	6,631,084 $338 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $38.5 Million - $47.7 Million	714,677 Added 17.04%	4,908,059 $264 Million
Q2 2022 Aug 11, 2022	BUY	$63.83 - $80.0 $80.8 Million - $101 Million	1,265,278 Added 43.21%	4,193,382 $269 Million
Q1 2022 May 11, 2022	BUY	$76.85 - $89.45 $116 Million - $135 Million	1,510,751 Added 106.59%	2,928,104 $227 Million
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $69.8 Million - $81.6 Million	935,663 Added 194.25%	1,417,353 $122 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $35.5 Million - $40.3 Million	481,690 New	481,690 $38.7 Million

Others Institutions Holding BAX

# of Institutions

949

Shares Held

473M

Call Options Held

3.84M

Put Options Held

2.32M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Baxter International Inc Transaction History